ATE449186T1 - Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung - Google Patents

Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung

Info

Publication number
ATE449186T1
ATE449186T1 AT02794065T AT02794065T ATE449186T1 AT E449186 T1 ATE449186 T1 AT E449186T1 AT 02794065 T AT02794065 T AT 02794065T AT 02794065 T AT02794065 T AT 02794065T AT E449186 T1 ATE449186 T1 AT E449186T1
Authority
AT
Austria
Prior art keywords
methods
compositions
nucleic acid
acid isolation
selective nucleic
Prior art date
Application number
AT02794065T
Other languages
English (en)
Inventor
Douglas Bost
Lawrence Greenfield
Original Assignee
Applied Biosystems Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23305266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE449186(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Biosystems Llc filed Critical Applied Biosystems Llc
Application granted granted Critical
Publication of ATE449186T1 publication Critical patent/ATE449186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02794065T 2001-11-28 2002-11-27 Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung ATE449186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33402901P 2001-11-28 2001-11-28
PCT/US2002/038123 WO2003046146A2 (en) 2001-11-28 2002-11-27 Compositions and methods of selective nucleic acid isolation

Publications (1)

Publication Number Publication Date
ATE449186T1 true ATE449186T1 (de) 2009-12-15

Family

ID=23305266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02794065T ATE449186T1 (de) 2001-11-28 2002-11-27 Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung

Country Status (7)

Country Link
US (5) US7208271B2 (de)
EP (1) EP1448799B2 (de)
JP (3) JP4106026B2 (de)
AT (1) ATE449186T1 (de)
AU (1) AU2002359522A1 (de)
DE (1) DE60234464D1 (de)
WO (1) WO2003046146A2 (de)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2003046146A2 (en) 2001-11-28 2003-06-05 Applera Corporation Compositions and methods of selective nucleic acid isolation
JP3644641B2 (ja) * 2003-03-07 2005-05-11 株式会社日立ハイテクノロジーズ 核酸回収方法
JP4241183B2 (ja) * 2003-05-19 2009-03-18 株式会社日立ハイテクノロジーズ 核酸回収方法及び核酸回収キット
US20050009036A1 (en) * 2003-07-11 2005-01-13 Applera Corporation Methods and kits for obtaining nucleic acid from biological samples
EP1654361B2 (de) * 2003-07-25 2023-01-18 Life Technologies Corporation Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
WO2005012487A2 (en) * 2003-08-01 2005-02-10 Invitrogen Corporation Compositions and methods for preparing short rna molecules and other nucleic acids
JP2005270049A (ja) * 2004-03-26 2005-10-06 Jfe Steel Kk 核酸分子の切断方法
JP2005295869A (ja) * 2004-04-09 2005-10-27 Jfe Steel Kk 核酸分子の切断方法およびその装置
KR100714988B1 (ko) * 2005-08-09 2007-05-09 삼성전자주식회사 산화막이 표면에 형성된 실리콘 구조물 표면을 이용한ｄｎａ 정제 방법 및 정제장치
WO2007070381A2 (en) 2005-12-09 2007-06-21 Promega Corporation Nucleic acid purification with a binding matrix
WO2007133495A1 (en) * 2006-05-10 2007-11-22 Human Genome Sciences, Inc. Mixture for decreasing protein interference
US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification
EP3260556B1 (de) * 2006-05-31 2019-07-31 Sequenom, Inc. Verfahren zur nukleinsäureextraktion aus einer probe
DE102006031764B4 (de) * 2006-07-06 2009-10-01 Aj Innuscreen Gmbh Verfahren zur parallelen Isolierung doppel- und einzelsträngiger Nukleinsäuren sowie zur selektiven Entfernung doppelsträngiger Nukleinsäuren aus einem Gemisch von doppel- und einzelsträngigen Nukleinsäuren
JP4297148B2 (ja) * 2006-09-22 2009-07-15 ソニー株式会社 核酸回収装置及び核酸回収方法
GB0719022D0 (en) * 2007-09-28 2007-11-07 Mole Genetics As Isolation method
US7871764B1 (en) * 2008-03-18 2011-01-18 The United States Of America As Represented By The United States Department Of Energy Universal nucleic acids sample preparation method for cells, spores and their mixture
EP2414545B1 (de) 2009-04-03 2017-01-11 Sequenom, Inc. Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
US8222397B2 (en) * 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
DK2588609T3 (en) 2010-06-29 2018-03-19 Exscale Biospecimen Solutions Ab METHOD AND KIT FOR SEQUENTIAL ISOLATION OF NUCLEOTIDE SPECIES FROM A SAMPLE
EP2591102B1 (de) 2010-07-07 2015-05-13 Diagon Kft. Verfahren zur spezifischen isolierung des dna-gesamtgehalts bakterieller erreger und kit für diesen zweck
DK2742152T3 (en) * 2011-08-12 2017-07-31 Qiagen Gmbh PROCEDURE FOR ISOLATING NUCLEIC ACIDS
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
US20140322706A1 (en) 2012-10-24 2014-10-30 Jon Faiz Kayyem Integrated multipelx target analysis
EP3427830B1 (de) 2012-10-24 2021-06-23 Genmark Diagnostics Inc. Integrierte multiplex-zielanalyse
JP6351702B2 (ja) 2013-03-15 2018-07-04 ジェンマーク ダイアグノスティクス， インコーポレイテッド 変形可能流体容器を操作するためのシステム、方法、および装置
US9498778B2 (en) 2014-11-11 2016-11-22 Genmark Diagnostics, Inc. Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system
USD881409S1 (en) 2013-10-24 2020-04-14 Genmark Diagnostics, Inc. Biochip cartridge
WO2016065218A1 (en) 2014-10-23 2016-04-28 Corning Incorporated Polymer-encapsulated magnetic nanoparticles
US10005080B2 (en) 2014-11-11 2018-06-26 Genmark Diagnostics, Inc. Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation
US9598722B2 (en) 2014-11-11 2017-03-21 Genmark Diagnostics, Inc. Cartridge for performing assays in a closed sample preparation and reaction system
JP2017537616A (ja) 2014-11-14 2017-12-21 コーニング インコーポレイテッド インビトロ転写後のｒｎａ精製のための方法及びキット
WO2017040992A1 (en) 2015-09-04 2017-03-09 Mo Bio Laboratories, Inc. Methods for co-isolation of nucelic acids and proteins
WO2018119452A2 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
PL3885445T3 (pl) 2017-04-14 2024-01-29 Guardant Health, Inc. Sposoby przyłączania adapterów do próbek kwasów nukleinowych
WO2019060640A1 (en) 2017-09-20 2019-03-28 Guardant Health, Inc. METHODS AND SYSTEMS FOR DIFFERENTIATING SOMATIC VARIANTS AND GERMINAL LINE VARIANTS
WO2019090147A1 (en) 2017-11-03 2019-05-09 Guardant Health, Inc. Correcting for deamination-induced sequence errors
WO2019090156A1 (en) 2017-11-03 2019-05-09 Guardant Health, Inc. Normalizing tumor mutation burden
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
CN108456675A (zh) * 2018-03-27 2018-08-28 爱默基因（厦门）生物科技有限公司 一种用于凝胶DNA回收的溶胶buffer、回收凝胶DNA的试剂盒及其使用方法
JP7546486B2 (ja) 2018-04-13 2024-09-06 ガーダント ヘルス， インコーポレイテッド 融合事象によって引き起こされるアライメントエラーを検出および抑制する方法
CN118599962A (zh) 2018-04-24 2024-09-06 凯杰科技有限公司 从复杂样品中分离核酸并去除抑制剂
JP2021526791A (ja) 2018-06-04 2021-10-11 ガーダント ヘルス， インコーポレイテッド セルフリー核酸の細胞起源を決定するための方法およびシステム
AU2019310041B2 (en) 2018-07-23 2025-11-20 Guardant Health, Inc. Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
CA3109646A1 (en) 2018-08-30 2020-03-05 Guardant Health, Inc. Methods and systems for detecting contamination between samples
SG11202101400UA (en) 2018-08-31 2021-03-30 Guardant Health Inc Microsatellite instability detection in cell-free dna
WO2020047553A1 (en) 2018-08-31 2020-03-05 Guardant Health, Inc. Genetic variant detection based on merged and unmerged reads
JP7637615B2 (ja) 2018-09-04 2025-02-28 ガーダント ヘルス， インコーポレイテッド 無細胞核酸試料におけるアレル不均衡を検出するための方法およびシステム
EP3874060B1 (de) 2018-10-31 2024-10-16 Guardant Health, Inc. Verfahren und system zur kalibrierung epigenetischer partitionstests
JP2022514010A (ja) 2018-12-20 2022-02-09 ガーダント ヘルス， インコーポレイテッド 核酸分子の回収率を改善するための方法、組成物、およびシステム
CA3126428A1 (en) 2019-01-31 2020-08-06 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
KR20210132139A (ko) 2019-02-27 2021-11-03 가던트 헬쓰, 인크. 대립유전자 빈도에 기초한 기능 손실의 컴퓨터 모델링
WO2020176659A1 (en) 2019-02-27 2020-09-03 Guardant Health, Inc. Methods and systems for determining the cellular origin of cell-free dna
US11939636B2 (en) 2019-05-31 2024-03-26 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
CA3151538A1 (en) 2019-09-30 2021-04-08 Stefanie Ann Ward Mortimer Compositions and methods for analyzing cell-free dna in methylation partitioning assays
EP4715839A2 (de) 2019-10-11 2026-03-25 Guardant Health, Inc. Verwendung von zellfreien bakteriellen nukleinsäuren zum nachweis von krebs
US11447819B2 (en) 2019-10-25 2022-09-20 Guardant Health, Inc. Methods for 3′ overhang repair
CN114746560A (zh) 2019-11-26 2022-07-12 夸登特健康公司 改进甲基化多核苷酸结合的方法、组合物和系统
JP7763764B2 (ja) 2020-01-31 2025-11-04 ガーダント ヘルス， インコーポレイテッド 標的バリアントがクローンレベルで存在しないことの有意性モデリング
JP7813712B2 (ja) 2020-03-11 2026-02-13 ガーダント ヘルス， インコーポレイテッド 無細胞核酸において検出された遺伝的突然変異を、腫瘍起源または非腫瘍起源として分類するための方法
CA3177127A1 (en) 2020-04-30 2021-11-04 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
US12241126B2 (en) 2020-05-14 2025-03-04 Guardant Health, Inc. Homologous recombination repair deficiency detection
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
EP4179111B1 (de) 2020-07-10 2024-04-03 Guardant Health, Inc. Verfahren zum nachweis von genomischen neuanordnungen unter verwendung zellfreier nukleinsäuren
WO2022026761A1 (en) 2020-07-30 2022-02-03 Guardant Health, Inc. Methods for isolating cell-free dna
JP7588815B2 (ja) 2020-08-17 2024-11-25 株式会社ミズホメディー Ｒｎａろ過器及びｒｎａろ過方法
WO2022046947A1 (en) 2020-08-25 2022-03-03 Guardant Health, Inc. Methods and systems for predicting an origin of a variant
EP4205122A2 (de) 2020-08-27 2023-07-05 Guardant Health, Inc. Rechnerische detektion von kopienzahlvariationen an einem locus in abwesenheit von direkter messung des locus
WO2022073012A1 (en) 2020-09-30 2022-04-07 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease
WO2022087309A1 (en) 2020-10-23 2022-04-28 Guardant Health, Inc. Compositions and methods for analyzing dna using partitioning and base conversion
CA3199829A1 (en) 2020-11-30 2022-06-02 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
WO2022140629A1 (en) 2020-12-23 2022-06-30 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
EP4729633A2 (de) 2021-02-12 2026-04-22 Guardant Health, Inc. Verfahren zum nachweis von nukleinsäurevarianten
JP2024513668A (ja) 2021-03-05 2024-03-27 ガーダント ヘルス， インコーポレイテッド 分子応答を分析するための方法および関連する態様
WO2022192889A1 (en) 2021-03-09 2022-09-15 Guardant Health, Inc. Detecting the presence of a tumor based on off-target polynucleotide sequencing data
EP4314329A1 (de) 2021-03-25 2024-02-07 Guardant Health, Inc. Verfahren und zusammensetzungen zur quantifizierung von immunzellen-dna
WO2022251655A1 (en) 2021-05-28 2022-12-01 Guardant Health, Inc. Compositions and methods for assaying circulating molecules
EP4359562A1 (de) 2021-06-21 2024-05-01 Guardant Health, Inc. Verfahren und zusammensetzungen zur analyse von aus dem ausgangsgewebe informierten kopienzahl-daten
EP4388091A2 (de) 2021-08-20 2024-06-26 Guardant Health, Inc. Verfahren zur gleichzeitigen molekularen und probenbarcodierung
WO2023056065A1 (en) 2021-09-30 2023-04-06 Guardant Health, Inc. Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
JP2024540168A (ja) 2021-11-02 2024-10-31 ガーダント ヘルス， インコーポレイテッド 品質管理方法
EP4453241A1 (de) 2021-12-21 2024-10-30 Guardant Health, Inc. Verfahren und systeme zur kombinatorischen chromatin-ip-sequenzierung
WO2023122740A1 (en) 2021-12-23 2023-06-29 Guardant Health, Inc. Compositions and methods for detection of metastasis
EP4567129A3 (de) 2022-02-02 2025-08-13 Guardant Health, Inc. Multifunktionelle primer für gepaarte sequenzierungsablesungen
EP4504971A1 (de) 2022-04-07 2025-02-12 Guardant Health, Inc. Nachweis des vorhandenseins eines tumors auf grundlage des methylierungsstatus von zellfreien nukleinsäuremolekülen
EP4523213A1 (de) 2022-05-09 2025-03-19 Guardant Health, Inc. Erkennung von verschleiss auf der basis von strangvorspannung
EP4547857A1 (de) 2022-06-30 2025-05-07 Guardant Health, Inc. Anreicherung von anomal methylierter dna
CN119923475A (zh) 2022-07-21 2025-05-02 夸登特健康公司 用于检测和减少样品制备诱导的甲基化人为假象的方法
JP2025532567A (ja) 2022-09-16 2025-10-01 ガーダント ヘルス， インコーポレイテッド 可溶性タンパク質を解析するための組成物および方法
WO2024073508A2 (en) 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
KR20250110272A (ko) 2022-11-15 2025-07-18 가던트 헬쓰, 인크. 순환 종양 dna (ctdna)로부터 기준선 ctdna 수준 및 시간 경과에 따른 ctdna 수준의 종단적 변화 둘 다로부터의 신호를 이용하여 비소세포 폐암 (nsclc) 환자 약물 반응 또는 사망 또는 암 진행까지의 시간을 예측하는 방법
CN120226085A (zh) 2022-11-17 2025-06-27 夸登特健康公司 用于在无细胞dna液体活检测定中对非肿瘤变异进行分类的生物信息学模型的验证
KR20250138733A (ko) 2022-12-21 2025-09-22 가던트 헬쓰, 인크. 세포-유리 핵산 분자의 메틸화 상태에 기초한 상동 재조합 결핍의 검출
WO2024138180A2 (en) 2022-12-22 2024-06-27 Guardant Health, Inc. Integrated targeted and whole genome somatic and dna methylation sequencing workflows
EP4638781A2 (de) 2022-12-22 2025-10-29 Guardant Health, Inc. Verfahren mit methylierungsbewahrender amplifikation mit fehlerkorrektur
EP4655416A1 (de) 2023-01-25 2025-12-03 Guardant Health, Inc. Verfahren zur erstellung von nukleinsäuremethylierungprofilen
WO2024186768A1 (en) 2023-03-07 2024-09-12 Guardant Health, Inc. Hybrid ssdna- and dsdna-ngs library preparation methods
US20250078955A1 (en) 2023-04-07 2025-03-06 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
WO2024229143A1 (en) 2023-05-01 2024-11-07 Guardant Health, Inc. Quality control method for enzymatic conversion procedures
EP4705508A1 (de) 2023-05-03 2026-03-11 Guardant Health, Inc. Verfahren zur analyse von dna-methylierung
EP4705522A1 (de) 2023-05-05 2026-03-11 Guardant Health, Inc. Zellfreier dna-blutbasierter test für krebsscreening
WO2024259251A1 (en) 2023-06-15 2024-12-19 Guardant Health, Inc. Method for hrd detection in targeted cfdna samples using de novo mutational signatures
WO2024264065A1 (en) 2023-06-23 2024-12-26 Guardant Health, Inc. Methods and compositions for quantifying immune cell nucleic acids
WO2025029475A1 (en) 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection
WO2025038399A1 (en) 2023-08-11 2025-02-20 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
US20250084469A1 (en) 2023-09-12 2025-03-13 Guardant Health, Inc. Methods for analyzing nucleic acids using sequence read family size distribution
WO2025064706A1 (en) 2023-09-19 2025-03-27 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
US20250246266A1 (en) 2023-09-29 2025-07-31 Guardant Health, Inc. Genotyping cyp2d6
WO2025076452A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
WO2025090956A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants using capture probes
WO2025090954A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants
WO2025090646A1 (en) 2023-10-27 2025-05-01 Guardant Health, Inc. Monitoring molecular response by allelic imbalance
WO2025137620A1 (en) 2023-12-21 2025-06-26 Guardant Health, Inc. Methods for high quality and high accuracy methylation sequencing
WO2025137389A2 (en) 2023-12-22 2025-06-26 Guardant Health, Inc. Methods for targeted single-molecule genetic and epigenetic sequencing
WO2025160433A1 (en) 2024-01-24 2025-07-31 Guardant Health, Inc. Methods for analyzing sequencing reads
WO2025207817A1 (en) 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
US20250308636A1 (en) 2024-03-27 2025-10-02 Guardant Health, Inc. Inferring cnvs from the distribution of molecules in hyper partition
WO2025207941A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for separating cpg-dense dna by binding of cpg-binding proteins and methyl-sensitive deamination
WO2025208044A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for cancer detection using molecular patterns
US20250308629A1 (en) 2024-04-01 2025-10-02 Guardant Health, Inc. Small variant calling with error-rate based model
WO2025235889A1 (en) 2024-05-10 2025-11-13 Guardant Health, Inc. Methods involving multiplexed pooled pcr
WO2025250544A1 (en) 2024-05-31 2025-12-04 Guardant Health, Inc. Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
WO2026015607A1 (en) 2024-07-09 2026-01-15 Guardant Health, Inc. Methods for partitioning hyper-, hypo-, and non-methylated dna
WO2026015794A1 (en) 2024-07-12 2026-01-15 Guardant Health, Inc. Methods for modifying dna using cpg-specific deamination and uracil base excision
WO2026024817A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Methods and compositions for anchored multiplex ngs workflows
WO2026024956A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Selecting low technical noise biomarkers for sensitive molecular diagnostics
WO2026024692A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Direct methylation single-base resolution sequencing of enriched unmethylated dna
WO2026043702A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods and approaches for personalized identification and monitoring of extrachromosomal circular dna
WO2026043718A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods to monitor patients treated with a cancer vaccine
WO2026050179A1 (en) 2024-08-26 2026-03-05 Guardant Health, Inc. Tumor fraction (tf) is associated with real-world progression-free survival (rwpfs) in non-small-cell lung cancer (nsclc) patients treated with platinum-based chemotherapy (chemo)
WO2026050287A1 (en) 2024-08-27 2026-03-05 Guardant Health, Inc. Methylation biomarkers for osimertinib treatment management
WO2026060266A1 (en) 2024-09-13 2026-03-19 Guardant Health, Inc. Use of copy number variants for the identification of false positive tumor calls
WO2026064529A2 (en) 2024-09-18 2026-03-26 Guardant Health, Inc. Methods for detecting nucleic acid variants using primers and ligation substrates
WO2026073140A1 (en) 2024-09-27 2026-04-02 Guardant Health, Inc. Framework to identify genomic regions indicative of one or more biological conditions
WO2026076332A1 (en) 2024-10-03 2026-04-09 Guardant Health, Inc. Methods involving multi-modal tumor variant identification and tracking of tumor molecules
WO2026080838A2 (en) 2024-10-11 2026-04-16 Guardant Health, Inc. Methods for detecting nucleic acid variants
WO2026090570A1 (en) 2024-10-24 2026-04-30 Guardant Health, Inc. Detecting the presence of a biological condition based on a nucleic acid sample data analysis
WO2026096358A1 (en) 2024-10-28 2026-05-07 Guardant Health, Inc. Screening approaches for high cancer risk individuals
WO2026096627A1 (en) 2024-10-29 2026-05-07 Guardant Health, Inc. Methods for high-plexity extracellular vesicle protein characterization through immunopcr/ngs
WO2026096657A1 (en) 2024-10-29 2026-05-07 Guardant Health, Inc. Methods for highly multi-plexed detection and quantification of co-localized membrane surface proteins

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340674A (en) * 1980-05-05 1982-07-20 The Upjohn Company Cointegrate plasmids and their construction from plasmids of Escherichia and Streptomyces
US4420517A (en) 1982-05-06 1983-12-13 Becton Dickinson And Company Methods for improving uniformity of silica films on substrates
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
DE3308932A1 (de) 1983-03-12 1984-09-13 Hoechst Ag, 6230 Frankfurt Verfahren zur abtrennung von ribonukleinsaeuren aus einer loesung, die desoxyribonukleinsaeuren enthaelt
US5137816A (en) * 1983-06-22 1992-08-11 The Lubrizol Corporation Rhizobial diagnostic probes and rhizobium trifolii nifH promoters
US4648975A (en) 1983-08-17 1987-03-10 Pedro B. Macedo Process of using improved silica-based chromatographic supports containing additives
GB8519457D0 (en) * 1985-08-02 1985-09-11 Faulk Ward Page Tumour imaging agents
CA1301606C (en) 1986-05-02 1992-05-26 David H. Gillespie Chaotropic method for evaluating nucleic acids in a biological sample
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US4923978A (en) 1987-12-28 1990-05-08 E. I. Du Pont De Nemours & Company Process for purifying nucleic acids
US5075430A (en) 1988-12-12 1991-12-24 Bio-Rad Laboratories, Inc. Process for the purification of DNA on diatomaceous earth
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
NL8900725A (nl) 1989-03-23 1990-10-16 Az Univ Amsterdam Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
AU5126890A (en) 1989-04-03 1990-10-04 Minnesota Mining And Manufacturing Company Metal oxide supports for nucleic acids
US5175271A (en) 1989-07-10 1992-12-29 University Of Kansas Use of silica gel for DNA extraction with organic solvents
US5106966A (en) 1989-07-10 1992-04-21 University Of Kansas Use of gel polymer for dna extraction with organic solvents
US5533888A (en) * 1990-08-21 1996-07-09 Belarde; John F. Apparatus for forming concrete barriers
WO1992018514A1 (en) 1991-04-12 1992-10-29 Minnesota Mining And Manufacturing Company Purification of nucleic acids using metal oxide supports
CA2067711C (en) 1991-05-03 2000-08-08 Daniel Lee Woodard Solid phase extraction purification of dna
US5155018A (en) * 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
US5329000A (en) 1991-10-31 1994-07-12 Becton, Dickinson And Company Purification of DNA with silicon tetrahydrazide
DE4143639C2 (de) * 1991-12-02 2002-10-24 Qiagen Gmbh Verfahren zur Isolierung und Reinigung von Nukleinsäuren
US5346994A (en) 1992-01-28 1994-09-13 Piotr Chomczynski Shelf-stable product and process for isolating RNA, DNA and proteins
EP0555798B1 (de) 1992-02-13 1999-05-06 Becton, Dickinson and Company Celithydrat und Reinigung von DNS
CA2102264C (en) 1992-11-13 2000-08-01 Daniel Lee Woodard Boron silicates, aluminum silicates, phosphosilicates and purification of dna
DE4321904B4 (de) 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
WO1995004140A1 (en) 1993-07-28 1995-02-09 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
DE69433425T2 (de) 1993-08-30 2004-10-07 Promega Corp Zusammensetzungen und verfahren zur reinigung von nukleinsäuren
US5637687A (en) 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
US5438129A (en) 1993-09-27 1995-08-01 Becton Dickinson And Company DNA purification by solid phase extraction using partially fluorinated aluminum hydroxide adsorbant
US5438127A (en) 1993-09-27 1995-08-01 Becton Dickinson And Company DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane
US5503816A (en) 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
JP3256238B2 (ja) 1994-02-11 2002-02-12 クイアジェン・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 二本鎖／単鎖核酸構造物の分離方法
US5705628A (en) * 1994-09-20 1998-01-06 Whitehead Institute For Biomedical Research DNA purification and isolation using magnetic particles
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
GB9425138D0 (en) * 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US5576196A (en) 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
US5777099A (en) 1995-02-24 1998-07-07 Biotecx Laboratories, Inc. RNA separation
JP2965131B2 (ja) 1995-07-07 1999-10-18 東洋紡績株式会社 核酸結合用磁性担体およびそれを用いる核酸単離方法
US6291166B1 (en) * 1997-04-16 2001-09-18 Xtrana, Inc. Nucleic acid archiving
US5945515A (en) * 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
US5804684A (en) 1995-08-24 1998-09-08 The Theobald Smith Research Institute, Inc. Method for isolating nucleic acids
US5783686A (en) 1995-09-15 1998-07-21 Beckman Instruments, Inc. Method for purifying nucleic acids from heterogenous mixtures
DE29601618U1 (de) 1996-01-31 1996-07-04 InViTek GmbH, 13125 Berlin Vorrichtung zur gleichzeitigen multiplen Isolierung
GB9602825D0 (en) 1996-02-12 1996-04-10 Therexsys Ltd Method of plasmid dna production and purification
US5973137A (en) 1996-02-13 1999-10-26 Gentra Systems, Inc. Low pH RNA isolation reagents, method, and kit
KR100483498B1 (ko) 1996-02-14 2005-07-18 악조 노벨 엔.브이. 핵산물질의분리및증폭방법
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
DE69719409T2 (de) 1996-06-18 2004-01-15 Rikagaku Kenkyusho Verfahren zur Reinigung von DNS
EP0818461B1 (de) 1996-07-12 2005-09-28 Toyo Boseki Kabushiki Kaisha Verfahren zur Isolierung von Ribonucleinsäuren.
US5981235A (en) 1996-07-29 1999-11-09 Promega Corporation Methods for isolating nucleic acids using alkaline protease
CA2214495C (en) 1996-09-25 2002-02-05 Daniel L. Woodard Hydrated zirconium silicate composition for purification of nucleic acids
WO1998026284A1 (en) 1996-12-11 1998-06-18 Nycomed Amersham Plc Selective lysis of cells
WO1998045311A1 (en) 1997-04-10 1998-10-15 Life Technologies, Inc. Rna isolation reagent and methods
EP1023460A4 (de) 1997-06-25 2003-09-10 Promega Corp Verfahren zur isolierung von rna
US5972613A (en) 1997-12-09 1999-10-26 The Perkin-Elmer Corporation Methods of nucleic acid isolation
DE19801730A1 (de) 1998-01-19 1999-07-22 Fraunhofer Ges Forschung Verfahren zur kombinierten Analyse von Zellinhalten, insbesondere den in biologischen Zellen enthaltenen Nukleinsäuren sowie Vorrichtung zur Durchführung des Verfahrens
EP1053357B1 (de) 1998-02-02 2008-05-21 QIAGEN North American Holdings, Inc. Verfahren zur isolierung, amplifizierung und charakterisierung von dns
DE59912604D1 (de) 1998-02-04 2005-11-03 Merck Patent Gmbh Verfahren zur isolierung und aufreinigung von nucleinsäuren
JP2002516663A (ja) 1998-04-02 2002-06-11 リー キュンジル ガラス微細繊維コラムとこれを利用したプラスミドＤＮＡ製造および精製方法（ＧｌａｓｓｍｉｃｒｏｆｉｂｅｒｃｏｌｕｍｎａｎｄｍｅｔｈｏｄｆｏｒｔｈｅｐｒｅｐａｒａｔｉｏｎａｎｄｐｕｒｉｆｉｃａｔｉｏｎｏｆｐｌａｓｍｉｄＤＮＡｕｓｉｎｇｔｈｅｓａｍｅ）
EP0969090A1 (de) * 1998-05-27 2000-01-05 QIAGEN GmbH Schnelles und einfaches Verfahren zur Isolierung von zirkulären Nucleinsäuren
AU4367500A (en) * 1999-04-21 2000-11-02 Annovis, Inc. Magnetic dna extraction kit for plants
US6270970B1 (en) 1999-05-14 2001-08-07 Promega Corporation Mixed-bed solid phase and its use in the isolation of nucleic acids
WO2001014590A2 (en) 1999-08-20 2001-03-01 Promega Corporation Simultaneous isolation and quantitation of dna
US7001724B1 (en) † 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
WO2003033739A1 (en) * 2001-10-12 2003-04-24 Gentra Systems, Inc. Compositions and methods for using a solid support to purify rna
WO2003046146A2 (en) 2001-11-28 2003-06-05 Applera Corporation Compositions and methods of selective nucleic acid isolation

Also Published As

Publication number Publication date
JP2005510233A (ja) 2005-04-21
WO2003046146A3 (en) 2004-02-26
US8507198B2 (en) 2013-08-13
JP2009039137A (ja) 2009-02-26
AU2002359522A1 (en) 2003-06-10
US7208271B2 (en) 2007-04-24
JP2008000146A (ja) 2008-01-10
US20070224630A1 (en) 2007-09-27
US20150086988A1 (en) 2015-03-26
WO2003046146A2 (en) 2003-06-05
US20140065626A1 (en) 2014-03-06
EP1448799B1 (de) 2009-11-18
EP1448799B2 (de) 2018-05-16
EP1448799A4 (de) 2006-03-08
EP1448799A2 (de) 2004-08-25
JP4106026B2 (ja) 2008-06-25
US8865405B2 (en) 2014-10-21
US7537898B2 (en) 2009-05-26
US20030138828A1 (en) 2003-07-24
DE60234464D1 (de) 2009-12-31
AU2002359522A8 (en) 2003-06-10
US20100021905A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
DE60234464D1 (de) Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
DE50113023D1 (de) Verfahren zur Konditionierung von organischen Pigmenten
DE60230672D1 (de) Nukleinsäureanreicherung
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE602004032160D1 (de) Verfahren zur Zubereitung von Getränken
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
DE50213074D1 (de) Verfahren zur Herstellung UV-vernetzter Acrylathaftklebemassen
DE60210265D1 (de) Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
ATA11042002A (de) Verfahren zur simulation des fahrverhaltens von fahrzeugen
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
DE60122429D1 (de) Verfahren zur Hydrierung von Kohlenwasserstoffschnitten
DE602005001156D1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
ATE469908T1 (de) Verfahren zur herstellung von pimecrolimus
DE50201891D1 (de) Verfahren zur herstellung von 1-octen
DE60226766D1 (de) Verfahren zur herstellung von phenolischen novolaken
DE60223070D1 (de) Verfahren zur herstellung von dihalogenadamantanen
EP1443820A4 (de) Zusammensetzung und verfahren zur behandlung der transplantat-wirt-reaktion
DE60219193D1 (de) Verfahren zur herstellung von silylorganomercaptanen
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
DE50210487D1 (de) Verfahren zur Herstellung von 1-Amino-4-hydroxyanthrachinonen
DE59905922D1 (de) Verfahren zur Isolierung von Glykolen
DE60329036D1 (de) Ökologisches verfahren zur herstellung von brombenzol
ATE340873T1 (de) Verfahren zur durchführung einer subtraktiven hybridisierung
DE60319093D1 (de) Verfahren zur isolierung eines intestilanen cholesterin bindenproteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties